Albarico, Anunciacion A.

HRN: 00-51-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/25/2022
05/01/2022
IV
600 Mg
Q8hrs
Empiric
Waiting Final Action 
04/26/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/26/2022
05/03/2022
IV
1.5g
Q6h
Cellulitis
Waiting Final Action 
04/27/2022
CEFTRIAXONE 1G (VIAL)
04/27/2022
05/03/2022
IV
2g
Q24
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: